Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Multi-site neuroimaging datasets are difficult to integrate due to confounding site effects. ComBat has been a widely used statistical-based model for this type of harmonization. Nevertheless, it suffers some drawbacks which prevent its application in external validation frameworks in machine learning (ML) analyses. First, ComBat relies on all current sites to estimate model parameters, leading to the necessity of re-fitting the model when data from new unseen sites is added. Then, it requires the inclusion of biological information of interest (e.g. diagnosis) in the model fitting process, which is incompatible with the harmonization of samples with unknown outcomes, a necessary condition to develop AI applications based on predictive models to be employed in clinical settings. In this work, we propose to solve the former issues by employing modified ComBat (M-ComBat) in a normative framework (NM-ComBat). To assess its harmonization efficacy, we compared four different ComBat variations, including its standard application (S-ComBat), M-ComBat, and the normative variation of the latter, NS-ComBat and NM-ComBat, in harmonizing a multi-site functional connectivity (FC) dataset. Our results show that NM-ComBat enabled the successful harmonization of external datasets, successfully eliminating site effects from data, while preserving biological covariates of interest, such as age, sex, and diagnosis. These results paved the way for the application of ComBat in ML analysis and external validation frameworks, contributing to the generalizability of developed models and their potential clinical applicability.

Original publication

DOI

10.1109/MetroXRAINE62247.2024.10796816

Type

Conference paper

Publication Date

01/01/2024

Pages

400 - 404